United States Interventional Neurology Devices Market 2025: Industry Developments, Future Growth, Share & Industry Insights | Medtronic, Stryker, Johnson & Johnson, Penumbra Inc, Terumo Corporation

Global interventional neurology devices market size reached US$ 2.31 Billion in 2024 from US$ 2.18 Billion in 2023 and is expected to reach US$ 4.11 Billion by 2033, growing at a CAGR of 6.7% during the forecast period 2025-2033.

Get a Free Sample Research PDF: https://datamintelligence.com/download-sample/interventional-neurology-devices-market?sg

USA - Industry developments 2025:

✅ [2025-01-06] Stryker announced a definitive agreement to acquire Inari Medical (≈$4.9B) - a major M&A that broadens Stryker's vascular footprint and has implications for its neuro/peripheral vascular strategy.

✅ [2025-02-19] Stryker completed the Inari acquisition (closing/update from Stryker).

✅ [2025-01-29] FDA granted 510(k) clearance to Imperative Care's large-bore thrombectomy catheter (Zoom system / Zoom DuoPort expansion) - a key product launch/clearance expanding options for mechanical thrombectomy.

✅ [2025-03-18] FDA classified the recall of certain Medtronic Pipeline Vantage embolization devices as the most serious (linked to injuries/deaths) regulatory and market-impact event affecting aneurysm/flow-diversion device availability and usage.

✅ (2025, ongoing) Penumbra continued clinical/portfolio updates around its CAVT (computer-assisted vacuum thrombectomy) platform and presented new data at conferences - continuing the "end-to-end" thrombectomy competition in the U.S. market.

Europe - Industry developments 2025:

✅ [2025-01-22] Lauxera Capital Partners invested €50M into Acandis (Germany) - a sizable growth capital move for an established European neurovascular device maker (supports R&D/expansion).

✅ [2025-06 (April-July) 2025] Acandis supported and launched clinical initiatives (e.g., ICARUS study / RESOLVE study approvals and the SiREX/SiREX-stent activity) - active clinical program growth across Europe.

✅ [2025-02-28] phenox (Wallaby/phenox Limited) - the pRESET Delta thrombectomy device received an FDA 510(k) decision (decision date in FDA record) - notable because a Europe-origin device progressed through U.S. regulatory channels, underscoring EU companies' global ambitions.

✅ (2025, ongoing) Several European smaller players (Acandis, phenox and others) actively expanding clinical trials, investigator-led studies and CE/market activity - Europe remains a source of novel thrombectomy/stent/coil innovations.

Japan - Industry developments 2025:

✅ [2025-05-13] Terumo Neuro announced US commercial availability / physician data updates for the SOFIATM 88 neurovascular support catheter (Terumo is Japan-headquartered and continues to invest in neurovascular catheters and support devices). This reflects product rollouts from Japanese OEMs and their global commercialization moves.

✅ [2025 - FY/2025 activity] Terumo reorganized business names and continued R&D/portfolio refinements across cardiac & vascular businesses signalling strategic alignment to global neurovascular trends.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/interventional-neurology-devices-market?sg

Regional share & dynamics:

➠ North America - market leader. North America holds the largest share thanks to advanced hospital infrastructure, widespread stroke-center networks, strong R&D and early commercial uptake of novel devices. (Most market reports list North America as the dominant region.)

➠ Europe - mature, innovation-friendly market. Western Europe is the second largest region by value, with established neurointerventional programs and growing adoption across major EU markets.

➠ Asia-Pacific - fastest growth. APAC (China, India, Japan, South Korea, Southeast Asia) is often flagged as the fastest-growing region due to rising incidence, expanding hospital capacity, and increasing access to specialized care making it the primary growth opportunity for vendors.

Key market growth drivers:

✅ Rising stroke & neurovascular disease burden. Increasing incidence of ischemic and hemorrhagic stroke (ageing populations and changing risk profiles) is the primary demand engine for acute interventional treatments such as mechanical thrombectomy and flow diversion.

✅ Shift to minimally invasive endovascular procedures. Clinicians and health systems prefer less-invasive options with faster recovery; expansion of thrombectomy indications and improved outcomes are accelerating device adoption.

✅ Technology & product innovation. New generation thrombectomy devices, coated stents, improved flow diverters, microcatheters, and adjunct imaging/guide systems are expanding treatable patient populations and procedure success rates.

✅ Improved neuroimaging & diagnosis. Wider access to CT/MR perfusion and stroke networks means more eligible patients are identified quickly for intervention.

✅ Health-system investment & reimbursement evolution. Increasing reimbursement for endovascular stroke care and broader build-out of stroke centers in many regions supports market growth.

Segments Covered in the Interventional Neurology Devices Market:

By Device Type (Neurovascular Stents, Embolic Coils, Aspiration Catheters, Microcatheters and Guidewires, Balloon Catheters, and Others)

By Indication (Ischemic Stroke, Hemorrhagic Stroke, Cerebral Aneurysm, Arteriovenous Malformation, Carotid/Extra-Cranial Stenosis, and Others)

By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others)

Regional Analysis for Interventional Neurology Devices Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Buy Now & Get 30% OFF - Grab 50% OFF on 2+ reports: https://www.datamintelligence.com/buy-now-page?report=interventional-neurology-devices-market?sg

Major Key Players: Medtronic, Stryker, Johnson & Johnson, Penumbra, Inc., Terumo Corporation, Boston Scientific Corporation, MicroPort Scientific Corporation, and Acandis GmbH.

Unlimited Insights. One Subscription: https://www.datamintelligence.com/reports-subscription?sg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.